VERI, CHEK and CZOO among mid-day movers
Seeking Alpha News (Tue, 26-Mar 12:55 PM ET)
NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers
Seeking Alpha News (Tue, 26-Mar 10:00 AM ET)
GOEV, NBSE and FLGC among pre-market losers
Seeking Alpha News (Tue, 26-Mar 8:15 AM ET)
Ampio Pharmaceuticals announces voluntary delisting and SEC deregistration
Seeking Alpha News (Mon, 25-Mar 5:09 PM ET)
Ampio Announces Voluntary Delisting and SEC Deregistration
PRNewswire (Mon, 25-Mar 5:00 PM ET)
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Seeking Alpha News (Sun, 24-Mar 8:01 AM ET)
Ampio Provides Update on Results from Pre-IND Enabling Studies
PRNewswire (Wed, 14-Feb 5:45 PM ET)
Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions
PRNewswire (Thu, 11-Jan 4:15 PM ET)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the clinical development of Ampion and preclinical development. Its product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19-induced respiratory distress.
Ampio Pharmaceuticals trades on the AMEX stock market under the symbol AMPE.
As of March 28, 2024, AMPE stock price climbed to $0.92 with 50,843 million shares trading.
AMPE has a beta of 1.27, meaning it tends to be more sensitive to market movements. AMPE has a correlation of 0.03 to the broad based SPY ETF.
AMPE has a market cap of $1.04 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that AMPE belongs to (by Net Assets): VXF.
AMPE has underperformed the market in the last year with a price return of -80.9% while the SPY ETF gained +33.6%. AMPE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -58.2% and -44.9%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
AMPE support price is $.75 and resistance is $.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMPE stock will trade within this expected range on the day.